News
Biologic benefit in psoriasis might extend to arthritis prevention
- Author:
- Sara Freeman
People with psoriasis had a lower risk for psoriatic arthritis if they had been treated with a biologic than if they had not, based on a study of...
News
Vertebral fractures still a risk with low-dose oral glucocorticoids for RA
- Author:
- Sara Freeman
Vertebral, not other, osteoporotic fractures were increased in current versus past users of low-dose steroids in a retrospective cohort study.
News
Pharmacovigilance data implicate three new drugs in ANCA-associated vasculitis
- Author:
- Sara Freeman
Mirabegron, sofosbuvir, and nintedanib join a list of 12 other drugs that have been linked to an overreporting of drug-associated ANCA vasculitis...
News
TNF inhibitors have delayed effect on spondyloarthritis radiographic progression
- Author:
- Sara Freeman
It could take 2-4 years before plain radiographs show any sign of a benefit on the spine or sacroiliac joints.
News
Mavrilimumab may aid severe COVID-19 recovery
- Author:
- Sara Freeman
The granulocyte/macrophage-colony stimulating factor (GM-CSF) blocker reduced the need for mechanical ventilation and death by day 29 versus...
News
Patients with RA on rituximab at risk for worse COVID-19 outcomes
- Author:
- Sara Freeman
Risk mitigation strategies such as social distancing and wearing masks, especially indoors, remain important for people being treated with...
News
GRAPPA refines recommendations on psoriatic disease treatment
- Author:
- Sara Freeman
Biosimilars, Janus kinase inhibitors, and interleukin-23 inhibitors will feature in the 2021 update.
News
BEAT-LUPUS: Belimumab after rituximab delays severe flares
- Author:
- Sara Freeman
Results from a phase 2b trial are “clearly encouraging” and “support the hypothesis that BAFF [B-cell–activating factor] can drive flares after...
News
EULAR COVID-19 recommendations set for update
- Author:
- Sara Freeman
Conclusions drawn from a systematic literature review largely appear to reinforce the recommendations that have already been made but need further...
News
Trastuzumab deruxtecan-related lung disease in MBC patients can occur anytime in first year
- Author:
- Sara Freeman
Pooled data from phase 1 and 2 trials show that rates of interstitial lung disease in metastatic breast cancer...
News
Endocrine therapy benefits in premenopausal breast cancer differ by molecular risk
- Author:
- Sara Freeman
High-risk patients may gain most benefit from goserelin while low-risk patients may be better off with tamoxifen...
News
GELATO trial: Chemoimmunotherapy may help in metastatic invasive lobular breast cancer
- Author:
- Sara Freeman
First results from the phase 2, single-arm study suggest immune induction with an atezolizumab and carboplatin...
News
No survival dip with neoadjuvant letrozole-palbociclib in NeoPAL study
- Author:
- Sara Freeman
Similar survival results were seen in the phase 2 study that compared the preop use of the combination or...
News
BERENICE: Further evidence of heart safety of dual HER2 blockade
- Author:
- Sara Freeman
Few cardiac events were seen at 5-year follow-up in patients treated with pertuzumab-trastuzumab and neoadjuvant...
News
Rituximab’s serious infection risk in ANCA-vasculitis allayed by antibiotic use
- Author:
- Sara Freeman
Co-use of co-trimoxazole decreased the risk for infection, which remains high in patients with vasculitis who are treated with rituximab.